Efficacy of the tris-salt of 2 [(methoxycarbonylamino)-[2-nitro-5-(n-propylthio) phenylimimo] methylamino] ethane sulfonic acid against inhibited larvae of Ostertagia ostertagi.
The tris-salt of 2-[(methoxy-carbonylamino) - [2-nitro-5-(n-propylthio) phenylimimo] methylamino] ethane sulfonic acid (MCA) was evaluated against naturally acquired gastrointestinal parasitism in cattle during spring in Louisiana to determine efficacy of the compound against inhibited early 4th-stage larvae (EL4) of Ostertagia ostertagi. Forty-three crossbred yearling beef heifers were grazed together on contaminated pastures between Mar 1 and Apr 18, 1984. On April 17, 3 of the 43 heifers were slaughtered. Analysis of worm population characteristics in the 3 cattle indicated sufficient numbers of O ostertagi EL4 and other worm genera and species in these cattle to pursue a valid evaluation of the anthelmintic efficacy of MCA. The remaining 40 heifers were removed from pasture on April 18. On April 24, they were allotted into 4 treatment groups (10/group) based on an equal distribution of body weights and on whether they were spring- or autumn-born cattle. On April 25, the cattle were treated as follows: group 1, nontreated controls; group 2, treated with MCA at 7.5 mg/kg of body weight by oral drench; group 3, treated with MCA at 15.0 mg/kg by oral drench; and group 4, treated with MCA at 20.0 mg/kg by oral drench. The cattle were then confined in drylot pens until May 7. Similar numbers of cattle from each group were killed over a 3-day period from May 8 to May 10 (13 to 15 days after treatment). Mean numbers of O ostertagi recovered from nontreated controls were: adults, 8,279; developing 4th-stage larvae, 2,806; and inhibited EL4, 12,070.(ABSTRACT TRUNCATED AT 250 WORDS)
D000018:Abomasum / Q000382:microbiology; D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000382:microbiology; D006146:Guanidines / Q000627:therapeutic use*; D009348:Nematoda / Q000302:isolation & purification; D010029:Ostertagiasis / Q000188:drug therapy / Q000662:veterinary*; D014252:Trichostrongyloidiasis / Q000662:veterinary*
D006146:Guanidines; C049116:2-((methoxycarbonylamino)-(2-nitro-5-(n-propylthio)phenylimino)methylamino)ethansulfonic acid